Analyst firms · Deutsche Bank · ACHC
Deutsche Bank ACHC price target and rating history
Acadia Healthcare Company Inc. (ACHC) · Health Care
Deutsche Bank rates Acadia Healthcare Company Inc. (ACHC) Buy with a $75 price target, as of its latest action on Dec 12, 2024. It has published 3 rating actions on ACHC since April 2023, including 2 upgrades and 1 downgrade. Across 4 firms with a ACHC price target in the last 12 months, the median target is $22.
- Current rating
- Buy
- Price target
- $75
- Median target, all firms
- $22
- Actions on ACHC
- 3
Deutsche Bank price target on ACHC
Every Deutsche Bank rating on ACHC
- Dec 12, 2024
- Apr 25, 2024
- Apr 20, 2023
How other firms rate ACHC
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Raymond James | Outperform | $39 | Sep 28, 2026 |
| Jefferies | Buy | $30 | Jun 3, 2026 |
| Leerink Partners | Market Perform | $14 | Dec 3, 2025 |
| BofA Securities | Underperform | $13 | Dec 3, 2025 |
Questions about Deutsche Bank and ACHC
- What is Deutsche Bank's price target for ACHC?
- Deutsche Bank's latest stated price target for Acadia Healthcare Company Inc. (ACHC) is $75, from its action on Dec 12, 2024.
- What is Deutsche Bank's rating on ACHC?
- Deutsche Bank rates ACHC Buy, a bullish rating, as of Dec 12, 2024.
- When did Deutsche Bank last change its view on ACHC?
- On Dec 12, 2024, Deutsche Bank upgrades to Buy from Hold, price target $45 to $75.
- How does Deutsche Bank's ACHC target compare with other analysts?
- Across 4 firms with a ACHC price target in the last 12 months, the median target is $22.
More ACHC rating histories
All Deutsche Bank ratingsACHC news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.